Langerhans cell histiocytosis: a rare cause of exudative enteropathy in a young child
| Autor: | G. B. Movsisyan, A. D. Komarova, K. A. Kulikov, I. I. Kalinina, M. M. Lokhmatov, V. I. Oldakovskiy, R. F. Tepaev, E. A. Roslavtseva, A. S. Potapov, N. E. Shchigoleva, A. I. Materikin, K. V. Savostyanov |
|---|---|
| Rok vydání: | 2023 |
| Předmět: | |
| Zdroj: | Pediatric Hematology/Oncology and Immunopathology. 22:110-121 |
| ISSN: | 2414-9314 1726-1708 |
| Popis: | Exudative enteropathy is a clinical syndrome characterized by excessive loss of proteins through the gastrointestinal tract and is a rare complication of various gastrointestinal diseases. One of the rarest causes of protein malabsorption is Langerhans cell histiocytosis, which occurs as a result of inflammatory neoplasia of myeloid precursor cells caused by mutations in the mitogenactivated protein kinase pathway. Abnormal proliferation and accumulation of Langerhans cells in the intestinal wall leads to a violation of the outflow of lymph, and causes clinical manifestations characteristic of enteropathy. Given that the lesion of the gastrointestinal tract with histiocytosis from Langerhans cells occurs in 2–3% of cases, and the clinical signs are not highly specific, timely diagnosis is difficult. Delayed verification of the diagnosis and late initiation of adequate treatment are risk factors for multisystem lesions and lead to an unfavorable outcome. The literature describes a few observations of the onset or manifestation of the disease with symptoms of protein malabsorption. We present a rare clinical case of diagnosing histiocytosis from Langerhans cells in a young child with severe manifestations of exudative enteropathy at the onset. The patient's parents gave their consent to the use of their child's data, including photographs, for research purposes and in publications.Refractory gastrointestinal symptoms require mandatory endoscopic and histological examination to identify rare causes of malabsorption. Timely initiation of targeted therapy with vemurafenib in combination with subsequent chemotherapy provided the child with a favorable prognosis and stable remission of the disease. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|